CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Trial of AMG 386 and Temsirolimus in Advanced Solid Tumors With an Expansion Cohort in Uterine Cancer, Renal Cell Carcinoma and Carcinoid Tumor

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01548482
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:06.012003+00:00
Published At: 2015-10-06T00:00:00+00:00
Record Updated At: 2015-10-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adult Solid Neoplasm", "Lung Carcinoid Tumor", "Recurrent Digestive System Neuroendocrine Tumor G1", "Recurrent Renal Cell Carcinoma", "Recurrent Uterine Corpus Sarcoma", "Stage III Renal Cell Cancer", "Stage IIIB Uterine Sarcoma", "Stage IIIC Uterine Sarcoma", "Stage IV Renal Cell Cancer", "Stage IVA Uterine Sarcoma", "Stage IVB Uterine Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-10-06"
protocolSection.identificationModule.nctId: "NCT01548482"
protocolSection.identificationModule.officialTitle: "A Phase I Trial of AMG 386 and Temsirolimus in Advanced Solid Tumors With an Expansion Cohort in Uterine Cancer, Renal Cell Carcinoma and Carcinoid Tumor"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.